Literature DB >> 15105324

Liver function tests: defining what's normal.

Paul Roderick1.   

Abstract

Mesh：

Year:  2004        PMID： 15105324      PMCID： PMC404495          DOI： 10.1136/bmj.38055.451968.55

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

2.  Alanine aminotransferase levels: what's normal?

Authors:  Marshall M Kaplan
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

3.  Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT.

Authors:  Ioannis Kyrlagkitsis; Bernard Portmann; Heather Smith; John O'Grady; Matthew E Cramp
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

4.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

5.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study.

Authors:  Hyeon Chang Kim; Chung Mo Nam; Sun Ha Jee; Kwang Hyub Han; Dae Kyu Oh; Il Suh
Journal:  BMJ       Date:  2004-03-17

6.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864
  6 in total
  4 in total

1.  The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI).

Authors:  David J McLernon; John F Dillon; Frank M Sullivan; Paul Roderick; William M Rosenberg; Stephen D Ryder; Peter T Donnan
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

2.  Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE).

Authors:  Peter T Donnan; David McLernon; Douglas Steinke; Stephen Ryder; Paul Roderick; Frank M Sullivan; William Rosenberg; John F Dillon
Journal:  BMC Health Serv Res       Date:  2007-04-16       Impact factor: 2.655

3.  Effect of occupational exposure to lead on serum levels of lipid profile and liver enzymes: An occupational cohort study.

Authors:  Ali Firoozichahak; Samira Rahimnejad; Abdolrasoul Rahmani; Ali Parvizimehr; Abbas Aghaei; Razzagh Rahimpoor
Journal:  Toxicol Rep       Date:  2022-02-26

4.  Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts.

Authors:  David J McLernon; Peter T Donnan; Frank M Sullivan; Paul Roderick; William M Rosenberg; Steve D Ryder; John F Dillon
Journal:  BMJ Open       Date:  2014-06-02       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.